Menu

Editas Medicine, Inc. EDIT

Full chart Compare
Set alert

Price alert · EDIT

All alert types
2.57 USD +0.02 (+0.78%)

At closeNov 6, 2026, 6:37 PM EST

2.57 0.00 0.00%

After hours · Nov 6, 6:37 PM ET

2.48 Day range 2.63
1.66 52-week range 3.75
YTD
+25.37%
1 year
-4.46%

Discussion (212)

Sign in to join the discussion

Vivian O'Neal EDIT 6 years ago #92

They should be worth much more bc of the potential to “cure” not treat.

Vivian O'Neal EDIT 6 years ago #94

Whole sector should get a nice boost and all that money deflating from the large caps could come ouf way and start some fires

Vivian O'Neal EDIT 6 years ago #95

Wow on gilead and immunomedics. What will edit be worth after some successful results on cancer. Keep it long and strong

Vivian O'Neal EDIT 6 years ago #96

Look at it this way. Once CRISPR is mastered aka gene editing it will produce cures on a level that doesn’t need to go further, it will attack viruses at the very basis of their existence. These companies are babies. Air bnb is going public with a $31BIL evaluation. These can go exponential, rest and repeat. Nothing here other then potential.

Vivian O'Neal EDIT 6 years ago #97

Think CRISPR group will wake up any day now. Billions of institutional money in these names. Use weakness to buy not cry. God bless